To include your compound in the COVID-19 Resource Center, submit it here.

Arixtra fondaparinux regulatory update

The CHMP issued a positive opinion to extend the label for GlaxoSmithKline's Arixtra

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE